Peptide Therapeutics and Industrial Chain Innovation Forum: A Billion-Dollar Market and the Future of Peptide Drugs
As an important branch of the biopharmaceutical field, peptide drugs have played a significant role in the prevention, diagnosis, and treatment of various diseases, including cancer, hepatitis, diabetes, and AIDS, owing to their broad indications, high safety profile, and remarkable efficacy.
In recent years, with continuous innovations in peptide drug molecular design and delivery technologies, key challenges that previously limited their clinical efficacy—such as difficulties with oral administration, short half-life, and poor cell membrane permeability—are gradually being overcome. This breakthrough has not only opened new avenues for the application of peptide drugs in rare diseases and chronic conditions but also spurred the emergence of a series of blockbuster drugs, such as glatiramer acetate and liraglutide, which have achieved remarkable success in the global market.
In particular, 2023 marked a new milestone for the peptide drug industry. Novo Nordisk’s semaglutide is projected to surpass $20 billion in sales, while Eli Lilly’s tirzepatide is expected to exceed $4 billion. These achievements not only highlight the immense market potential of peptide therapeutics but also reflect significant progress in technological innovation and indication expansion within the industry.
Against this backdrop, byVCBeat, VB100 JointBlueRun VenturesThe “Peptide Drugs and Industrial Chain Innovation Development Forum” to be held in MayHeld in Sub-venue 2 on the 8th.2024 Peptide Drug and Industry Chain Forum will bring together industry elites to jointly explore the innovative development trends of peptide drugs and collaborative synergy across the industry chain, injecting new momentum into the future development of the sector.
/Forum Agenda/
The 8th Future Healthcare Top 100 Conference has now been upgraded to the VBEF Future Healthcare Ecosystem Expo, which will be held onMay 7–10, 2024InBeijing · Beiren Yichuang International Convention and Exhibition CenterGrandly held. This exhibition is15,000+ Visits, 10,000 sqm Scale, focusing on new products and new technologies,New services, a new ecosystem, and new collaborative frameworks are being established, complemented by the launch of the VBEF channel on the VCBeat app, to create the premier platform for showcasing innovation in the healthcare industry.
Here is,
Here is,
Release of the Most Influential Rankings:Listed Companies’ Innovation Ranking + Future Healthcare 100 Ranking + Innovative Products Ranking: On-site Networking with 700+ Listed Enterprises!
Currently, there are alreadyOver 600 companies and products have confirmed their participation in the exhibition, with more than 90% of the exhibition space already booked., the global buyer team has collaborated withIndonesia, Singapore, Belgium, Ireland, Spain, Germany, Australia, the United Kingdom, Canada, and other countries. Limited partnership slots remain; enterprises, brands, buyer groups, and related organizations are welcome to discuss participation.
During the conference, download the VCBeat app and access the VBEF channel to receive real-time updates on keynote speeches, link to online exhibition resources, and instantly connect with companies featured on the authoritative VBEF rankings.
In this era of uncertainty, seeking high-value resources and efficient connections will be your top choice.
Sign Up Now—Limited-Time Offer!